CT
Contineum Therapeutics, Inc. Class A Common Stock
🇺🇸XNAS.CTNMUnited StatesHealthcare
$13.86USDdown -0.53 (-3.68%)OpenEnd of day3:29 PM
Price$13.86-0.53 (-3.68%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US21217B1008
- CUSIP
- 21217B100
Company
- Employees
- 51
- Headquarters
- San Diego, United States
- Website
- https://www.contineum-tx.com
- CEO
- Mr. Carmine N. Stengone MBA, MS
Market
- Shares outstanding
- 33M
- Market cap
- $453.55M
Key dates
- Next earnings
- Oct 29, 2026
Highlights
- Market cap
- $453.55M
- EPS LTM
- -$1.54
- P/E LTM
- -9.02calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$57.56M-1.22%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$53.46M-14.28%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.